Australia markets closed

Sutro Biopharma, Inc. (STRO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.5200+0.1000 (+2.92%)
At close: 04:00PM EDT
3.5500 +0.03 (+0.85%)
After hours: 06:24PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 270.76M
Enterprise value -71.22M
Trailing P/E 85.38
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.38
Price/book (mrq)1.81
Enterprise value/revenue -0.46
Enterprise value/EBITDA 1.23

Trading information

Stock price history

Beta (5Y monthly) 0.98
52-week change 3-23.48%
S&P500 52-week change 324.19%
52-week high 36.1300
52-week low 32.0100
50-day moving average 34.3302
200-day moving average 33.9704

Share statistics

Avg vol (3-month) 31M
Avg vol (10-day) 3630.33k
Shares outstanding 576.92M
Implied shares outstanding 676.92M
Float 849.42M
% held by insiders 10.90%
% held by institutions 179.52%
Shares short (15 Apr 2024) 42.18M
Short ratio (15 Apr 2024) 41.48
Short % of float (15 Apr 2024) 42.86%
Short % of shares outstanding (15 Apr 2024) 42.84%
Shares short (prior month 15 Mar 2024) 42.32M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -69.47%
Operating margin (ttm)37.94%

Management effectiveness

Return on assets (ttm)-12.71%
Return on equity (ttm)-58.25%

Income statement

Revenue (ttm)153.73M
Revenue per share (ttm)2.56
Quarterly revenue growth (yoy)1,217.40%
Gross profit (ttm)N/A
EBITDA -82.46M
Net income avi to common (ttm)-106.79M
Diluted EPS (ttm)-1.7800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)375.62M
Total cash per share (mrq)6.01
Total debt (mrq)33.63M
Total debt/equity (mrq)22.48%
Current ratio (mrq)4.50
Book value per share (mrq)2.45

Cash flow statement

Operating cash flow (ttm)-111.62M
Levered free cash flow (ttm)-30.58M